Abstract
Implant-associated infections are caused by microorganisms growing in biofilms, rendering these infections difficult to diagnose and to eradicate. Delayed-onset low-grade infection is difficult to distinguish from aseptic failure, often presenting without signs of infection, but only with early loosening and persisting pain. A combination of criteria is needed for an accurate diagnosis: clinical signs and symptoms, laboratory signs of infection, microbiology, histology, and imaging. The treatment goals in prosthetic joint-associated infection are eradication of infection and an optimal functional result. The goal in internal fixation device-associated infection is consolidation of the fracture and avoidance of chronic osteomyelitis. Successful treatment requires an adequate surgical procedure combined with long-term antimicrobial therapy, ideally with an agent acting on adhering biofilm microorganisms. This article reviews the epidemiology, pathogenesis, diagnosis, and management of implant-associated infections, and presents pathogenesis and risk of hematogenous infection.
Similar content being viewed by others
References and Recommended Reading
del Pozo JL, Patel R: The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther 2007, 82:204–209.
Zimmerli W, Trampuz A, Ochsner PE: Prosthetic-joint infections. N Engl J Med 2004, 351:1645–1654.
Steckelberg JM, Osmon DR: Prosthetic joint infection. In: Infections Associated with Indwelling Medical Devices, edn 3. Edited by Bisno AL, Waldvogel FA. Washington, DC: American Society for Microbiology; 2000:173–209.
Donlan RM: Biofilms: Microbial life on surfaces. Emerg Infect Dis 2002, 8:881–890.
Ochsner PE, Sirkin MS, Trampuz A: Acute infection. In: Principles of Fracture Management. Edited by Ruedi RP, Murphy WM. Stuttgart, Germany: Thieme Verlag; 2006.
Trampuz A, Hanssen AD, Osmon DR, et al.: Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 2004, 117:556–562.
Trampuz A, Piper KE, Hanssen AD, et al.: Sonication of explanted prosthetic components in bags for diagnosis of prosthetic joint infection is associated with risk of contamination. J Clin Microbiol 2006, 44:628–631.
Dora C, Altwegg M, Gerber C, et al.: Evaluation of conventional microbiological procedures and molecular genetic techniques for diagnosis of infections in patients with implanted orthopedic devices. J Clin Microbiol 2008, 46:824–825.
Esteban J, Gomez-Barrena E, Cordero J, et al.: Evaluation of quantitative analysis of cultures from sonicated retrieved orthopedic implants in diagnosis of orthopedic infection. J Clin Microbiol 2008, 46:488–492.
Trampuz A, Piper KE, Jacobson MJ, et al.: Sonication of removed hip and knee prostheses for improved diagnosis of infection. N Engl J Med 2007, 357:654–663.
Trampuz A, Osmon DR, Hanssen AD, et al.: Molecular and antibiofilm approaches to prosthetic joint infection. Clin Orthop 2003, 414:69–88.
Smith SL, Wastie ML, Forster I: Radionuclide bone scintigraphy in the detection of significant complications after total knee joint replacement. Clin Radiol 2001, 56:221–224.
Sonmezoglu K, Sonmezoglu M, Halac M, et al.: Usefulness of 99mTc-ciprofloxacin (Infecton) scan in diagnosis of chronic orthopedic infections: comparative study with 99mTc-HMPAO leukocyte scintigraphy. J Nucl Med 2001, 42:567–574.
Ivancevic V, Perka C, Hasart O, et al.: Imaging of low-grade bone infection with a technetium-99m labelled monoclonal anti-NCA-90 Fab’ fragment in patients with previous joint surgery. Eur J Nucl Med Mol Imaging 2002, 29:547–551.
Love C, Marwin SE, Tomas MB, et al.: Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J Nucl Med 2004, 45:1864–1871.
Stumpe KD, Notzli HP, Zanetti M, et al.: FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. Radiology 2004, 231:333–341.
Cheung A, Lachiewicz PF, Renner JB: The role of aspiration and contrast-enhanced arthrography in evaluating the uncemented hip arthroplasty. AJR Am J Roentgenol 1997, 168:1305–1309.
Brause BD: Infections with prostheses in bones and joints. In: Principles and Practice of Infectious Diseases, edn 6. Edited by Mandell GL, Bennett JE, Dolin R. New York: Elsevier, Churchill, Livingstone; 2005:1332–1337.
Widmer AF, Frei R, Rajacic Z, Zimmerli W: Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990, 162:96–102.
Widmer AF, Wiestner A, Frei R, Zimmerli W: Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother 1991, 35:741–746.
Zimmerli W, Frei R, Widmer AF, Rajacic Z: Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 1994, 33:959–967.
Zimmerli W, Widmer AF, Blatter M, et al.: Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998, 279:1537–1541.
Widmer AF, Gaechter A, Ochsner PE, Zimmerli W: Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992, 14:1251–1253.
Trebse R, Pisot V, Trampuz A: Treatment of infected retained implants. J Bone Joint Surg Br 2005, 87B:249–256.
Giulieri SG, Graber P, Ochsner PE, Zimmerli W: Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 2004, 32:222–228.
Laffer RR, Graber P, Ochsner PE, Zimmerli W: Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect 2006, 12:433–439.
Betsch BY, Eggli S, Siebenrock KA, et al.: Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis 2008, 46:1221–1226.
Brandt CM, Sistrunk WW, Duffy MC, et al.: Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997, 24:914–919.
Tsukayama DT, Wicklund B, Gustilo RB: Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics 1991, 14:841–844.
Crockarell JR, Hanssen AD, Osmon DR, Morrey BF: Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am 1998, 80:1306–1313.
Marculescu CE, Berbari EF, Hanssen AD, et al.: Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006, 42:471–478.
Ure KJ, Amstutz HC, Nasser S, Schmalzried TP: Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am 1998, 80:961–968.
Raut VV, Siney PD, Wroblewski BM: One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg Br 1994, 76:721–724.
Sendi P, Rohrbach M, Graber P, et al.: Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis 2006, 43:961–967.
Langlais F: Can we improve the results of revision arthroplasty for infected total hip replacement? J Bone Joint Surg Br 2003, 85:637–640.
van de BH, Neut D, Schenk W, et al.: Staphylococcus aureus biofilm formation on different gentamicin-loaded polymethylmethacrylate bone cements. Biomaterials 2001, 22:1607–1611.
Josefsson G, Gudmundsson G, Kolmert L, Wijkstrom S: Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. A five-year survey of 1688 hips. Clin Orthop Relat Res 1990, 173–178.
Trampuz A, Zimmerli W: Diagnosis and treatment of infections associated with fracture-fixation devices. Injury 2006, 37:S59–S66.
Trampuz A, Murphy CK, Rothstein DM, et al.: Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection. Antimicrob Agents Chemother 2007, 51:2540–2545.
Robertson GT, Bonventre EJ, Doyle TB, et al.: In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus. Antimicrob Agents Chemother 2008 (Epub ahead of print).
Shirtliff ME, Calhoun JH, Mader JT: Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits. J Antimicrob Chemother 2001, 48:253–258.
Soriano A, Gomez J, Gomez L, et al.: Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur J Clin Microbiol Infect Dis 2007, 26:353–356.
Bressler AM, Zimmer SM, Gilmore JL, Somani J: Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis 2004, 4:528–531.
Zimmerli W, Ochsner PE: Management of infection associated with prosthetic joints. Infection 2003, 31:99–108.
Carpenter CF, Chambers HF: Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis 2004, 38:994–1000.
Rao N, Regalla DM: Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series. Clin Orthop 2006, 451:34–37.
Maderazo EG, Judson S, Pasternak H: Late infections of total joint prostheses. A review and recommendations for prevention. Clin Orthop 1988, 299:131–142.
Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE: Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 1982, 146:487–497.
Zimmerli W, Lew PD, Waldvogel FA: Pathogenesis of foreign body infection: evidence for a local granulocyte defect. J Clin Invest 1984, 73:1191–1200.
Elek SD, Conen PE: The virulence of Staphylococcus pyogenes for man; a study of the problem of wound infection. Br J Exp Pathol 1957, 38:573–586.
Lucas VS, Lytra V, Hassan T, et al.: Comparison of lysis filtration and an automated blood culture system (BACTEC) for detection, quantification, and identification of odontogenic bacteremia in children. J Clin Microbiol 2002, 40:3416–3420.
Coulter WA, Coffey A, Saunders ID, Emmerson AM: Bacteremia in children following dental extraction. J Dent Res 1990, 69:1691–1695.
Zimmerli W, Zak O, Vosbeck K: Experimental hematogenous infection of subcutaneously implanted foreign bodies. Scand J Infect Dis 1985, 17:303–310.
Blomgren G, Lundquist H, Nord CE, Lindgren U: Late anaerobic haematogenous infection of experimental total joint replacement. A study in the rabbit using Propionibacterium acnes. J Bone Joint Surg Br 1981, 63B:614–618.
Deacon JM, Pagliaro AJ, Zelicof SB, Horowitz HW: Prophylactic use of antibiotics for procedures after total joint replacement. J Bone Joint Surg Am 1996, 78:1755–1770.
Murdoch DR, Roberts SA, Fowler JV Jr, et al.: Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis 2001, 32:647–649.
American Academy of Orthopaedic Surgeons: Antibiotic prophylaxis for dental patients with total joint replacements; 2004. [Information statement 1014.] Available at http://www.aaos.org/about/papers/advistmt/1014.asp. Accessed June 2008.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trampuz, A., Zimmerli, W. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr Infect Dis Rep 10, 394–403 (2008). https://doi.org/10.1007/s11908-008-0064-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11908-008-0064-1